Thermogenesis Holdings Inc (THMO) Inventory Turnover Ratio, from first quarter 2024 to first quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Thermogenesis Holdings Inc   (NASDAQ: THMO)
 

Thermogenesis Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Thermogenesis Holdings Inc inventory turnover ratio, the Thermogenesis Holdings Inc 's ability to sell and replace its inventory in the first quarter 2024, sequentially increased to 3.67 in the first quarter 2024, a new company high. Average inventory processing period, for the Thermogenesis Holdings Inc in Mar 31 2024 quarter, has decreased to 99 days, compare to 121 days, in the Dec 31 2023 quarter.

Within Healthcare sector 104 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2024, to 706, from total ranking in the fourth quarter 2023 at 949.

THMO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Thermogenesis Holdings Inc Market Share?

What is Inventory Turnover Ratio?




THMO Inventory Turnover Ratio (Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
Y / Y Inventory Growth -63.63 % -57.83 % -62.93 % -51.65 % -41.86 %
Y / Y Cost of Sales Growth -31.83 % 54.82 % -40.41 % -52.15 % -14.86 %
Inventory Turnover Ratio (TTM) 3.67 3.01 2.05 1.79 1.75
THMO's Total Ranking # 706 # 949 # 1118 # 1201 # 1475
Average inventory processing period 100 121 178 203 208
Seq. Inventory Growth -11.38 % -22.79 % -31.44 % -22.48 % 2.76 %
Seq. Cost of Sales Growth -71.7 % 253.3 % 0 % -31.83 % -35.71 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 4
Healthcare Sector # 105
Overall Market # 706

Inventory Turnover Ratio Statistics
High Average Low
3.67 1.98 0.69
(Mar 31 2024)   (Jun 30 2021)




Financial Statements
Thermogenesis Holdings Inc 's Inventories $ 1 Millions Visit THMO's Balance sheet
Thermogenesis Holdings Inc 's Cost of Revenues TTM $ 7 Millions Visit THMO's Income Statement
What are THMO's Sales? Visit THMO's Sales by Segment

Other Inventory Turnover Ratios
Thermogenesis Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
THMO's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for THMO's Competitors
Inventory Turnover Ratio for THMO's Suppliers
Inventory Turnover Ratio for THMO's Customers

You may also want to know
THMO's Sales Growth Rates THMO's Pe Price to earnings ratio THMO's Receivables Turnover Ratio THMO's Stock Quote
THMO's Net Income Growth Rates THMO's Ps Price to Sales ratio THMO's Sales per Employee THMO's Asset Turnover Ratio
THMO's Net Margin THMO's Pb Price to Book ratio THMO's Financial Strength Ratios THMO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2024 Inventories at quarter ending Mar 31 2024
Aspira Women s Health inc   14.31 $ 3.706  Millions$ 0  Millions
Natera Inc   14.19 $ 597.814  Millions$ 42  Millions
Option Care Health Inc   13.36 $ 3,441.157  Millions$ 258  Millions
Acadia Pharmaceuticals Inc   13.33 $ 62.922  Millions$ 5  Millions
Rockwell Medical inc   13.12 $ 76.223  Millions$ 6  Millions
Bioaffinity Technologies Inc   12.67 $ 0.152  Millions$ 0  Millions
Intelgenx Technologies Corp   12.44 $ 1.269  Millions$ 0  Millions
Irhythm Holdings Inc   11.81 $ 168.245  Millions$ 14  Millions
Sunlink Health Systems Inc   11.55 $ 18.800  Millions$ 2  Millions
Dermtech Inc   11.39 $ 12.484  Millions$ 1  Millions
Vanda Pharmaceuticals Inc   10.88 $ 13.462  Millions$ 1  Millions
Sotera Health Company  10.77 $ 483.913  Millions$ 45  Millions
Agile Therapeutics Inc  10.67 $ 30.497  Millions$ 3  Millions
Genedx Holdings Corp   10.57 $ 109.097  Millions$ 10  Millions
Infusystem Holdings Inc  10.37 $ 63.367  Millions$ 6  Millions
Myriad Genetics Inc   10.26 $ 241.600  Millions$ 24  Millions
Neuraxis Inc   9.86 $ 0.296  Millions$ 0  Millions
Cryo cell International Inc   9.85 $ 8.535  Millions$ 1  Millions
Novavax inc   9.80 $ 368.891  Millions$ 38  Millions
Invo Fertility Inc   9.73 $ 2.592  Millions$ 0  Millions
Moderna Inc   9.41 $ 3,997.000  Millions$ 425  Millions
Prosomnus Inc   8.81 $ 15.474  Millions$ 2  Millions
Puma Biotechnology Inc   8.76 $ 60.192  Millions$ 7  Millions
23andme Holding Co  8.74 $ 120.000  Millions$ 14  Millions
China Health Industries Holdings Inc   8.48 $ 0.101  Millions$ 0  Millions
Agape Atp Corporation  8.46 $ 0.481  Millions$ 0  Millions
Lantheus Holdings Inc   8.10 $ 490.292  Millions$ 61  Millions
Star Equity Holdings Inc   7.92 $ 33.323  Millions$ 4  Millions
Eton Pharmaceuticals Inc   7.88 $ 10.042  Millions$ 1  Millions
Mangoceuticals Inc   7.79 $ 0.152  Millions$ 0  Millions

Date modified: 2026-09-08T15:11:16+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.